Finn Sellebjerg

Research interests

Publications

• Locus for severity implicates CNS resilience in progression of multiple sclerosis

  Nature · 2023 · https://doi.org/10.1038/s41586-023-06250-x

• Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis

  JAMA Neurology · 2021 · 10.1001/jamaneurol.2021.2738

• Initial high-efficacy disease-modifying therapy in multiple sclerosis

  Neurology · 2020 · 10.1212/wnl.0000000000010135

• Serum neurofilament light as a biomarker in progressive multiple sclerosis

  Neurology · 2020 · 10.1212/wnl.0000000000010346

• Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

  JAMA Neurology · 2019 · https://doi.org/10.1001/jamaneurol.2019.1534

• Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

  Science · 2019 · https://doi.org/10.1126/science.aav7188

• Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

  The Lancet Neurology · 2018 · https://doi.org/10.1016/s1474-4422(18)30069-3

• Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

  The Lancet Neurology · 2018 · https://doi.org/10.1016/s1474-4422(18)30069-3

• Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

  Cell · 2018 · https://doi.org/10.1016/j.cell.2018.09.049

• Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

  CNS Drugs · 2014 · 10.1007/s40263-014-0140-z

• FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

  Nature Medicine · 2014 · 10.1038/nm.3485

• Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls

  The American Journal of Human Genetics · 2013 · 10.1016/j.ajhg.2013.04.019

• Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2770

• Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression

  PLoS ONE · 2013 · 10.1371/journal.pone.0057820

• Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

  Nature · 2011 · https://doi.org/10.1038/nature10251

• Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

  Multiple Sclerosis Journal · 2010 · 10.1177/1352458510389102

• Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

  Neurology · 2009 · 10.1212/wnl.0b013e3181c5b457

• T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis

  Immunology · 2008 · 10.1111/j.1365-2567.2008.02837.x

• Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force

  European Journal of Neurology · 2006 · https://doi.org/10.1111/j.1468-1331.2006.01493.x

• Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.

  PubMed · 2005 · 10.1001/archneur.62.6.865

• Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system

  Journal of Neuroimmunology · 2002 · 10.1016/s0165-5728(02)00097-8

• CCR1+/CCR5+ Mononuclear Phagocytes Accumulate in the Central Nervous System of Patients with Multiple Sclerosis

  American Journal Of Pathology · 2001 · 10.1016/s0002-9440(10)63017-9

• CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

  Journal of Neuroimmunology · 2000 · 10.1016/s0165-5728(99)00166-6

• Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

  Journal of Clinical Investigation · 1999 · https://doi.org/10.1172/jci5150

Current projects

No projects listed.